Investor helps Siva expand cancer study
Last Updated: 15:09 December 5, 2012
Boulder-based Siva Therapeutics will move into a 2,400-square-foot laboratory at 5541 Central Ave. in Boulder and hire a new bioengineer, said Len Pagliaro, chief executive of the four-person company. The amount of the investment and the name of the investor were not disclosed.
Siva Therapeutics' nanorod research involves minuscule rods that can be inserted into a cancer patient's body and heated to kill tumors. In October, the company received a $350,000 grant from San Francisco-based Thiel Foundation through its innovation program Breakout Labs.
Siva is using those funds to develop a portable infrared light that can be used in conjunction with rods made by NanoRods LLC, in Germantown, Maryland.
Nanorod research has been tested in pigs, Pagliaro has said in the past.
Siva Therapeutics plans to spend an estimated $25 million over seven years on pursuing approval to sell its SivaRod technology in the United States, Pagliaro has said.
More breaking news...
SNC expands collaboration on Dream Chaser
Vestas plans to hire more than 850 people at its four
NewMark thinks green on mall demolition
Centura to build 3 health, wellness centers
LONGMONT - In an effort to green its redevelopment of the Twin Peaks Mall, NewMark Merrill Mountain States announced this week plans for recycling and reusing materials from the "deconstruction" of the old shopping center.